medigraphic.com
SPANISH

Ginecología y Obstetricia de México

Federación Mexicana de Ginecología y Obstetricia, A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2018, Number 09

<< Back Next >>

Ginecol Obstet Mex 2018; 86 (09)

Correlation of uric acid and serum creatinine in pregnant patients with severe preeclampsia

Vázquez-Rodríguez JG, Isla-Arias MX
Full text How to cite this article

Language: Spanish
References: 17
Page: 567-574
PDF size: 303.02 Kb.


Key words:

Uric acid, Serum creatinine, Acute renal injury, Severe preeclampsia, Obstetric intensive care, High-risk pregnancy.

ABSTRACT

Objective: To determine the correlation of uric acid and creatinine in pregnant patients with severe preeclampsia to identify its clinical utility.
Material and Method: cross-sectional study that included 100 pregnant patients with severe preeclampsia. Blood levels of uric acid and creatinine were recorded upon admission to calculate the correlation of the general means and by categories. (Normal uric acid ≤ 4 mg/dL, hyperuricemia › 4 mg/dL and extreme hyperuricemia ≥7 mg/dL vs normal creatinine ≤ 0.9 mg/dL, hyperazotemia › 0.9 mg/dL and extreme hiperazoemia ≥ 1.1 mg/dL). Descriptive statistics, Student's T-test, Confidence intervals (CI) and Pearson's correlation coefficient were used with the statistical program SPSS version 20.
Results: 100 patients with severe preeclampsia were studied. The general average of uric acid was 5.52 ± 1.43 mg / dL; 85% had hyperuricemia and 17% extreme hyperuricemia. The general average of creatinine was 0.77 ± 0.25 mg / dL; 18% resulted with hyperazotemia and 14% with extreme azotemia.
Conclusions: Uric acid and creatinine showed positive correlations. It was found that the greater the degree of hyperuricemia, the greater the deterioration of renal function. Both markers can be complemented to identify acute kidney injury in severe preeclampsia.


REFERENCES

  1. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. 2011. Disponible en internet: http://apps.who.int/iris/bitstream/handle/ 10665/44703/9789241548335_eng.pdf;jsessionid=1C 88BFE2575BC51291D97B5ECD71F4E2?sequence=1

  2. Lo JO, et al. Hypertensive disease of pregnancy and maternal mortality. doi: 10.1097/GCO.0b013e32835e0ef5.

  3. Pridjian G, Puschett JB. Preeclampsia. Part 1: Clinical and pathophysiologic considerations. Obstet Gynecol Survey. 2000;57(9):598-618.

  4. American College of Obstetricians and Gynecologists (ACOG). Task Force on Hypertension in Pregnancy. Washington, DC. ACOG. November 2013;1-89. Disponible en internet: https://www.acog.org/~/media/Task%20 Force%20and%20Work%20Group%20Reports/public/ HypertensioninPregnancy.pdf

  5. Guía de Práctica Clínica. Actualización 2017. Prevención, Diagnóstico y Tratamiento de la preeclampsia en el segundo y tercer nivel de atención. México. Secretaría de Salud. 2017. Disponible en internet: http://www.cenetecdifusion. com/CMGPC/S-020-08/ER.pdf

  6. Stamilio DM, et al. Can antenatal clinical and biochemical markers predict the development of severe preeclampsia? Am J Obstet Gynecol. 2000;182(3):589-594.

  7. Powers RW, et.al. Uric acid concentrations in early pregnancy among preeclamptic women with gestational hyperuricemia at delivery. https://www.ajog.org/article/ S0002-9378(05)00969-5/pdf.

  8. Nelson DL, Cox MM (editores). Lehninger. Principios de Bioquímica. 3ª ed en español. Barcelona: Omega, 2001;860-7.

  9. Bainbridge S, Roberts JM. Uric acid as a pathogenic factor in preeclampsia. https://www.ncbi.nlm.nih.gov/pmc/ articles/PMC3319018/pdf/nihms45160.pdf.

  10. Mustafa R, et al. A comprehensive review of hypertension in pregnancy. https://pdfs.semanticscholar.org/8c3a/7f8b 5e01df37693ff2d61ea6c7aa1ef7accd.pdf

  11. Vázquez-Rodríguez JG, Rico-Trejo EI. Complicaciones maternas en pacientes con preeclampsia e hiperuricemia tratadas en la unidad de cuidados intensivos. Ginecol Obstet Mex. 2016;84(3):143-9.

  12. Vázquez-Rodríguez JG, Rico-Trejo EI. Papel del ácido úrico en la preeclampsia-eclampsia. Ginecol Obstet Mex. 2011;79(5):292-7.

  13. IMSS. Guías de práctica clínica. Detección y diagnostico de enfermedades hipertensivas del Embarazo. Instituto Mexicano del Seguro Social. http://www.imss.gob.mx/ sites/all/statics/guiasclinicas/058GER.pdf

  14. Chamy PV, et al. Perfil clínico de embarazadas con preeclampsia y embarazos no complicados. https://scielo. conicyt.cl/pdf/rchog/v69n5/art06.pdf.

  15. Voet D, Voet JG, Pratt ChW (editores). Fundamentos de Bioquímica. 2a edición en español. Buenos Aires: Médica Panamericana, 2007;809-14.

  16. Mehta RL, et al. Acute Kidney Injury Networt: report of an initiative to improve outcomes in acute kidney injury. http://akinet.org/pdf/AKIN_ICC_2007.pdf

  17. The Society of Obstetricians and Gynecologists of Canada. Clinical Practice Guideline. Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy: Executive Summary: https://sogc.org/wp-content/ uploads/2014/05/gui307CPG1405Erev.pdf




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ginecol Obstet Mex. 2018;86